ProQR Therapeutics
PRQR
PRQR
57 hedge funds and large institutions have $364M invested in ProQR Therapeutics in 2018 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 6 closing their positions.
Holders
57
Holders Change
+23
Holders Change %
+67.65%
% of All Funds
1.27%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
29
Increased
10
Reduced
13
Closed
6
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K
Top Buyers
1 |
1
Goldman Sachs
New York
|
$53.7M |
2 |
2
UBS Group
Zurich,
Switzerland
|
$45M |
3 |
3
BlackRock
New York
|
$11.1M |
4 |
4
HSBC Holdings
London,
United Kingdom
|
$7.89M |
5 |
5
T. Rowe Price Associates
Baltimore,
Maryland
|
$7.58M |
Top Sellers
1 |
RI
1
RTW Investments
New York
|
$7.07M |
2 |
RG
2
Redmile Group
San Francisco,
California
|
$0 |
3 |
O
3
OrbiMed
New York
|
$22.7M |
4 |
4
Morgan Stanley
New York
|
$4.96M |
5 |
NC
5
Nexthera Capital
New York
|
$0 |